Kyntra Bio, Inc. Common Stock (KYNB) is a publicly traded the market company. As of August 6, 2026, KYNB trades at $7.00 with a market cap of $28.01M and a P/E ratio of 0.00. KYNB moved +0.00% today. Year to date, KYNB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $6.32 to $9.70. Analyst consensus is strong buy with an average price target of $36.00. Rallies surfaces KYNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover KYNB: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $36.00.
| Metric | Value |
|---|---|
| Price | $7.00 |
| Market Cap | $28.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.70 |
| 52-Week Low | $6.32 |
| Volume | 455 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover KYNB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.00.